| Document |
Document Title |
|
JP3192410B1 |
[wrap up] [Task] Used as a general food material, health food material, or pharmaceutical material in the processing conditions, synthetic reaction conditions, and subsequent purification processes of raw materials for producing highly s...
|
|
JP3192411B1 |
[wrap up] [Task] The present invention relates to general food materials, health food materials, or general food materials or health food materials in the processing conditions, synthetic reaction conditions, and subsequent purification ...
|
|
JP3188069B2 |
PURPOSE: To economically obtain the derivative, having no malodor such as an olefin or an animal smell and capable of being blended with a cosmetic, etc., without carrying out the post-treatment according to a simple operation by reactin...
|
|
JP3188068B2 |
PURPOSE: To obtain the derivative of high quality with hardly any content of disterol esters which are by-products by thermally melting an alkenylsuccinic or an alkylsuccinic anhydride and then reacting the resultant melt with sterols. C...
|
|
JP3186309B2 |
PURPOSE: To obtain new compounds useful as an intermediate, etc., for a steroidal medicine, etc. CONSTITUTION: These compounds are expressed by formula I (X is H or alkyl; Y is hydroxyl group, alkyl, acyloxy or alkoxyl; X and Y together ...
|
|
JP3178046B2 |
PURPOSE: To obtain the subject derivative in good yield in a few steps by using a specific compound as a starting substance and subjecting the compound and a 4-vinyl-7-alkoxy-1,2-dihydronaphthalene to the asymmetric Diels-Alder reaction....
|
|
JP2001131197A |
To provide a method for producing a plant sterol having a high purity from a crude fatty acid ester derived from a vegetable oil and fat by a simple treatment. This method for producing the plant sterol from the crude fatty acid ester de...
|
|
JP2001131199A |
To provide a method for producing a highly pure plant sterol from a crude fatty acid ester derived from a vegetable oil and fat by a simple method in high yield. This method for producing the plant sterol comprises bringing the crude fat...
|
|
JP3165576B2 |
PURPOSE: To obtain the subject compound useful as a synthetic intermediate for vitamin D derivatives having physiological activity such as in vivo Ca regulating action in high yield by reacting a specific epoxy compound with alcohols und...
|
|
JP3145272B2 |
PURPOSE: To efficiently obtain the subject compound for a synthetic intermediate, etc., of active type vitamin D3 by treating a specific 1,4,6-triene-3-one compound in a mixed solvent of an aprotic solvent with alcohol in the presence of...
|
|
JP3133327B2 |
A pharmaceutical composition conatining at least one C3-OH ether or fatty acid monoester of 7B-hydroxycholesterol selected from the group consisting of the ethers or esters of palmitic, oleic, hexenoic, decenoic and arachindonic acids or...
|
|
JP3128579B2 |
PURPOSE: To enable mass-production of the subject compound which is useful in the metabolic study of catechol estrogen in high yield at low costs by glycosylation of 2-acetyl-estrogen followed by Bayer-Villiger oxidation and deprotection...
|
|
JP2000351798A |
To obtain a steroid compound useful as an intermediate for producing various kinds of vitamin D derivatives useful for the therapy of chronic renal failure, hypoparathyroidism, etc., by the solvolysis of the enol ester part of a specific...
|
|
JP2000351795A |
To obtain a steroid derivative as an intermediate for producing various kinds of vitamin D derivatives useful for the therapy of chronic renal failure, hypoparathyroidism, etc., by way of a process where a palladium compound is made to a...
|
|
JP2000351797A |
To obtain a steroid compound useful as an intermediate for producing various kinds of vitamin D derivatives useful for the therapy of chronic renal failure, hypoparathyroidism, etc., by epoxidizing a specific diene compound.A 1,2-epoxy-5...
|
|
JP2000351796A |
To obtain a steroid compound useful as an intermediate for producing various kinds of vitamin D derivatives useful for the therapy of chronic renal failure, hypoparathyroidism, etc., by oxidizing a specific steroid compound.A 1,2-epoxy c...
|
|
JP2000344676A |
To obtain the subject composition capable of decreasing the concentration level of a low density lipoprotein cholesterol and the total cholesterol in blood and useful for suppression or retardance of the crisis of atherosclerosis as much...
|
|
JP2000309600A |
To obtain new low-molecular compound capable of providing thermal recording media capable of performing a full-color display at a high speed and useful as a rewritable thermal display material and recording material. This compound is rep...
|
|
JP3105973B2 |
|
|
JP3096480B2 |
Bile acid derivatives of formula I wherein : R is hydrogen or hydroxy; X is a carboxy or a SO3H group, have valuable pharmacologic properties.
|
|
JP2000273099A |
To produce the subject derivative having a halogen atom at a specific position, capable of allowing various side chains to be introduced by utilizing the reactivity of the halogen atom, capable of allowing a protection step and a deprote...
|
|
JP2000510513A |
PCT No. PCT/EP97/02510 Sec. 371 Date Feb. 8, 1999 Sec. 102(e) Date Feb. 8, 1999 PCT Filed May 15, 1997 PCT Pub. No. WO97/43362 PCT Pub. Date Nov. 20, 1997The present invention relates to a process of treating an oil, the process comprisi...
|
|
JP3073803B2 |
The invention relates to the compounds: either n = 1, K = oxygen, R17 = hydroxyl, R'17 = hydrogen, ethynyl, RA = methyl, RA' = isopropyl, butyl, heptafluorobutyl, X = methylene, phenylene or phenyloxy, Y = -(CH2)7; -(CH2)8-; -(CH2)5-C ID...
|
|
JP2000128897A |
To obtain the subject high-purity compound without requiring a high- cost time-consuming purification process by stereoselectively subjecting a specific budesonide derivative to transketalization with butyraldehyde in the presence of a s...
|
|
JP3037507B2 |
PURPOSE: To prepare the new compounds each of which is useful as an intermediate for producing a pregnatrienedione type steroid compound. CONSTITUTION: The derivatives are compounds represented by the formula I (wherein: Hal is Cl or Br;...
|
|
JP3037427B2 |
Starting compounds for preparing calcitriol (1$g(a), 25-dihydroxycholecalciferol) and its derivatives showing, as compared with calcitriol, some modifications, particularly in the C-17 lateral chain, a method for preparing these starting...
|
|
JP2000072794A |
To obtain high purity esters of a sterol and a stannole in a good yield on a large scale, which enable them to be processed in a food grade without the existence of both any organic solvent and any inorganic acid by directly esterifying ...
|
|
JP2000072793A |
To obtain esters of a sterol and a stannole in a good yield, which enable a food grade process by directly esterifying a stannole and/or a sterol in the presence of both a color deactivator and a catalyst to separate their ester(s). (A) ...
|
|
JP2000063398A |
To efficiently obtain a high-purity labeled steroid from an obtainable general-purpose compound as a raw material useful for elucidating an organism function, etc., in a high yield by catalytically deuterating or catalytically tritiating...
|
|
JP2000017000A |
To obtain a steroid derivative useful as an intermediate for synthesizing various kinds of vitamin D compounds and activated vitamin D derivatives by reacting a specific phenylsulfone compound with a specific iodo derivative, etc., and f...
|
|
JP2999258B2 |
PCT No. PCT/EP91/01018 Sec. 371 Date Nov. 30, 1992 Sec. 102(e) Date Nov. 30, 1992 PCT Filed Jun. 3, 1991 PCT Pub. No. WO91/18918 PCT Pub. Date Dec. 12, 1991.A process for the production of 10 beta -H-11 beta -(substituted phenyl) steroid...
|
|
JP2986592B2 |
|
|
JPH11308991A |
To economically obtain a steroid useful as a medicine or the like by incubating a sterol compound in the presence of protein(s) produced by a specific process under such conditions as to enable a steroid to be oxidized and the resulting ...
|
|
JP2965352B2 |
The present invention relates to a novel process for the manufacture of (22 R,S)-16 alpha , 17 alpha -butylidenedioxy-11 beta , 21-dihydroxypregna-1,4-diene-3,20 dione (I) by reacting 11 beta , 16 alpha , 17 alpha 21-tetrahydroxypregna-1...
|
|
JP2963711B2 |
Genetically engineered host cells containing new expression cassettes are provided which are able to carry out biochemical oxidations of steroids. In particular the oxidation is carried out with cells into which DNA has been introduced w...
|
|
JP2965262B2 |
|
|
JPH11228593A |
To provide a method for readily purifying tall oil sterol in high purity at high recovery rate from tall oil neutral component. A tall oil neutral component is brought into contact with at least one kind of solvent selected from methanol...
|
|
JPH11199598A |
To obtain a ursodeoxycholic acid derivative having improved solubility in water and to provide a method for producing the derivative. This ursodeoxycholic acid derivative is obtained by bonding a saccharide through a spacer to ursodeoxyc...
|
|
JP2913608B2 |
A method of separating a first class of lipoprotein in a sample from a second class of lipoprotein in the sample including: precipitating the second class of lipoprotein; contacting the sample with a magnetically responsive particle; and...
|
|
JP2893906B2 |
|
|
JP2885386B2 |
An improved process for isolating organic compounds from crude product or reaction mixtures by dissolving said crude product or reaction mixture in a suitable solvent, contacting the resulting solution with a lithium salt to form a solid...
|
|
JP2837531B2 |
|
|
JP2834721B2 |
3-(Oxo or imino)-17 alpha -cyanomethylestra-4,9-diene 17 beta ethers and esters (I) are new: R1 = Me or Et; R2 = 1-10C alkyl, 1-10C acyl or trialkylsilyl; R3 = O or NOR; R = H; 1-10C acyl, 1-10C alkyl, sulphamoyl, or alkyl- or trialkylsi...
|
|
JP2834651B2 |
There is disclosed novel, therapeutically active androstane derivatives having neuromuscular blocking effect, which are substituted by a quaternary ammonium group in 16-position; pharmaceutically composition containing them; process for ...
|
|
JP2831549B2 |
|
|
JP2820256B2 |
This disclosure describes disulfide analogs of the family of antibacterial and antitumor agents known collectively as the LL-E33288 Complex.
|
|
JPH10509692A |
The invention relates to novel, androstane steroids which are the ligand semiochemicals which bind to neuroepithelial receptors. The steroids are useful as ligands to neuroepithelial receptors in the human vomeronasal gland to stimulate ...
|
|
JPH10509423A |
The invention relates to estrene steroids, which bind to neuroepithelial cells in the human vomeronasal organ. The steroids are preferably administered in the form of a pharmaceutical composition containing one or more pharmaceutically a...
|
|
JP2791046B2 |
The invention relates to a new process for the preparation of known aromatase inhibitors of the following formula wherein each of R1 and R3, independently, is hydrogen or C1-C6 alkyl; R2 is hydrogen, halogen or C1-C6 alkyl and R4 is hydr...
|
|
JPH10507176A |
The disclosed invention is a process for preparing 17-beta-substituted-androsta-3,5-dien-3-carboxylic acids from 3-halo-17-beta-substituted-androsta-3,5-dienes. The process may be performed in either of two ways: (1) the 3-halo compound ...
|
